RTA compliance certificate for Q1 FY27 filed with BSE under SEBI Reg 74(5)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals submitted to BSE the quarterly compliance certificate from its Registrar and Share Transfer Agent, Maashitla Securities, for the quarter ended 30 June 2026. The certificate confirms that any securities received from depository participants for dematerialisation were processed and listed on stock exchanges, and cancelled certificates were substituted in the register of members within 15 days. The attached tables for accepted and rejected demat requests during 01 April to 30 June 2026 are empty, indicating no dematerialisation activity in the quarter.
Routine procedural compliance filing. No material effect on shareholders or the stock price.